Diabetology & Metabolic Diseases

It is a well-known fact that overweight (having a BMI of 30 or above) are at greater risk of developing metabolic chronic disorders like type 2 diabetes mellitus, insulin resistance. Accumulation of adipose tissue affects metabolism by secreting hormones, glycerol, and other substances including leptin, cytokines, adiponectin, and proinflammatory substances, and non-esterified fatty acids which are involved in the development of insulin resistance and disruption of fat metabolism. And the secretion of these substances will be increased leading to diabetes in obese individuals

 

  • Bariatric surgery
  • Malabsorption
  • Cardiovascular risk factors

Related Conference of Diabetology & Metabolic Diseases

July 09-10, 2020

5th Annual Meet on Obesity and Diet

Vienna, Austria
July 20-21, 2020

16th Euro Obesity and Endocrinology Congress

Barcelona, Spain
July 20-20, 2020

Webinar on Obesity, Diet Management & Nutrition

Vancouver, Canada
July 20-21, 2020

21st World Congress on Obesity and Metabolic Diseases

Manila, Philippines
July 22-23, 2020

22nd Global Obesity, Diet and Nutrition Meeting

Melbourne, Australia
October 22-23, 2020

3rd International Conference on Obesity and Diet Imbalance

Helsinki, Finland

Diabetology & Metabolic Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in